Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-10 · accession 0000950170-25-005577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | 2025-01-10 | TMCI | Treace John T. | CEO, Dir, 10% | F - Tax | $0.00 | -11.9K | 6.51M | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-10 | F | D | 11,905 | $0.00 | 6,511,190 | D | — | — | (F1) Includes 151,882 restricted stock units |